Why this topic matters: Neuromuscular disorders can weaken the muscles that maintain airway patency, cough, swallowing and ventilation. Respiratory failure may develop quietly while oxygen saturation appears acceptable, especially when supplemental oxygen masks worsening carbon-dioxide retention. Myasthenic crisis, Guillain–Barré syndrome, spinal muscular atrophy, motor-neurone disease, muscular dystrophy, botulism, toxic paralysis and electrolyte disorders require early respiratory assessment, careful airway planning and specialist escalation. Use local Uganda protocols and senior critical-care/neurology supervision for ventilatory support and medicines.
Learning objectives
- Explain how neuromuscular weakness causes ventilatory, bulbar and airway failure.
- Recognise impending respiratory failure before exhaustion, cyanosis or cardiac arrest.
- Perform ABCDE, focused muscle and bulbar examination, serial respiratory measurements and neurological assessment.
- Outline emergency care for myasthenic crisis, Guillain–Barré syndrome, spinal cord disease, botulism and toxic/metabolic paralysis.
- Plan non-invasive/invasive ventilation, secretion clearance, medication safety, nursing care and rehabilitation referral.
What is neuromuscular failure?
Neuromuscular failure occurs when the nervous system, neuromuscular junction or muscles cannot generate enough force for effective breathing, coughing, swallowing or movement. Weakness may be acute, subacute or chronic with an acute trigger. The diaphragm and intercostal muscles may fail first, producing shallow breathing, fatigue and rising carbon dioxide. Bulbar weakness causes dysphagia, pooling secretions and aspiration; upper-airway weakness may lead to obstruction even when lung tissue is initially normal.
Oxygen saturation can remain normal until late because the patient compensates by increasing effort or receives supplemental oxygen. A falling vital capacity, weak cough, inability to count or speak in full sentences, orthopnoea, paradoxical breathing, drowsiness or rising CO₂ should trigger escalation even when SpO₂ looks reassuring.
Safety point: Do not wait for respiratory arrest. Neuromuscular patients can deteriorate rapidly after sedatives, opioids, infection, aspiration, electrolyte disturbance or transport. Call anaesthesia/critical care early and plan the airway while the patient is still cooperative.
Conditions and precipitating factors
| Condition | Emergency pattern | Common triggers or clues |
|---|---|---|
| Myasthenia gravis | Fluctuating ocular, bulbar and limb weakness; myasthenic crisis causes ventilatory failure. | Infection, surgery, pregnancy, missed pyridostigmine, interacting medicines or aspiration. |
| Guillain–Barré syndrome | Progressive symmetrical weakness, areflexia, autonomic instability and respiratory failure. | Recent respiratory/GI infection, rapid ascending weakness, facial or bulbar involvement. |
| Botulism/toxic paralysis | Descending paralysis, diplopia, fixed pupils, dysphagia and respiratory weakness. | Contaminated food, wound, injection exposure or infant botulism. |
| Spinal cord/brainstem disease | Weakness with sensory level, sphincter change, cranial-nerve signs or altered consciousness. | Trauma, stroke, compression, tumour or infection. |
| Muscular dystrophy/motor-neurone disease | Chronic weakness with acute infection, secretion retention or peri-operative failure. | Baseline low respiratory reserve and weak cough. |
| Metabolic/drug causes | Acute flaccid weakness, arrhythmia or altered mental status. | Hypokalaemia, hyperkalaemia, hypophosphataemia, organophosphate, magnesium/toxin or sedative exposure. |
Triage and first contact
- Place the patient in a monitored resuscitation-capable area and call senior emergency, neurology, anaesthesia and critical-care support.
- Ask about baseline mobility, speech, swallowing, cough, home ventilation, previous intubation, advance plan and usual respiratory measurements.
- Identify onset and progression: ocular symptoms, dysarthria, dysphagia, orthopnoea, inability to lie flat, limb weakness, sensory symptoms and recent infection.
- Review medicines carefully, including pyridostigmine, steroids, immunosuppressants, sedatives, opioids, magnesium, aminoglycosides, fluoroquinolones and beta-blockers.
- Keep the patient upright or in the position that improves breathing, suction secretions and prepare airway equipment before fatigue develops.
- Do not leave a weak patient alone in a waiting area; recheck respiratory effort and bulbar function frequently.
ABCDE assessment
| Step | What to assess | Actions |
|---|---|---|
| A – Airway | Voice, tongue/palate movement, gag/cough, pooling saliva, stridor and ability to protect airway. | Suction, positioning, airway adjuncts and early anaesthetic review; prepare for controlled intubation if failing. |
| B – Breathing | Rate, depth, paradoxical movement, accessory muscles, single-breath count, cough, SpO₂ and CO₂. | Oxygen for hypoxaemia, blood gas, serial vital capacity/forced vital capacity where available and ventilatory support. |
| C – Circulation | Pulse/BP, ECG, autonomic instability, dehydration, sepsis and arrhythmia. | IV access, cautious fluids when indicated, treat shock and monitor dysautonomia. |
| D – Disability | GCS, pupils, cranial nerves, ptosis, extraocular movement, limb power, reflexes and sensation. | Record baseline and trend; identify stroke, spinal cord, seizure or metabolic mimic. |
| E – Exposure | Fever, rash, trauma, injection sites, pressure areas and signs of aspiration. | Prevent hypothermia, search for infection/toxin and protect weak limbs. |
Warning signs of impending ventilatory failure
- Rapid shallow breathing, paradoxical abdominal movement or increasing accessory-muscle use.
- Orthopnoea, inability to lie flat, weak cough, repeated suctioning or inability to clear secretions.
- Bulbar symptoms: nasal speech, dysarthria, choking, drooling, wet voice or nasal regurgitation.
- Single-breath counting becomes shorter, speech is limited to a few words or the patient cannot lift the head.
- Falling vital capacity or inspiratory force, rising PaCO₂, respiratory acidosis, increasing fatigue or drowsiness.
- SpO₂ falling despite oxygen, recurrent aspiration, cyanosis or inability to cooperate with non-invasive support.
Monitoring and investigations
| Assessment | Why it matters | Emergency interpretation |
|---|---|---|
| Serial respiratory rate, effort and single-breath count | Shows fatigue and declining reserve. | Trend is more important than one isolated value; worsening effort requires escalation. |
| SpO₂ and blood gas | Detect oxygenation, CO₂ retention and acidosis. | Normal SpO₂ does not exclude hypercapnic failure; obtain gas when fatigue or hypoventilation is suspected. |
| Vital capacity/forced vital capacity | Quantifies respiratory muscle strength where reliable. | Use repeated measurements plus clinical signs; do not delay airway support for a number. |
| Peak cough flow and secretion assessment | Estimates ability to clear airway. | Weak cough, pooling secretions and aspiration need physiotherapy, suction or airway planning. |
| FBC, electrolytes, glucose, renal/liver profile | Find infection, metabolic weakness and drug-safety problems. | Correct potassium, phosphate, calcium or glucose abnormalities urgently. |
| ECG, chest imaging and cultures | Identify arrhythmia, aspiration, pneumonia, atelectasis or sepsis. | Treat the trigger without delaying respiratory support. |
| Neurology tests | EMG, nerve conduction, antibody tests, CSF and imaging may confirm cause. | Specialist-led; do not delay stabilisation for diagnostic certainty. |
Non-invasive and invasive ventilation
- Provide oxygen only for hypoxaemia and monitor CO₂; excessive oxygen can mask hypoventilation.
- Non-invasive ventilation may support selected cooperative patients with intact airway protection and manageable secretions. It is unsafe when there is severe bulbar failure, vomiting, shock, reduced consciousness or inability to remove the mask.
- Use cough-assist, suction, chest physiotherapy and assisted lung-volume recruitment where trained staff and equipment are available.
- Prepare early for endotracheal intubation when there is worsening hypercapnia/acidosis, exhaustion, recurrent aspiration, weak cough, persistent hypoxaemia, altered consciousness or inability to tolerate NIV.
- Intubation should be controlled by an experienced team because induction, neuromuscular blockers and positive pressure can cause profound deterioration.
- After intubation, confirm tube placement, secure it, provide lung-protective ventilation, analgesia/sedation, secretion care and frequent neurological/haemodynamic reassessment.
Myasthenic crisis
Myasthenic crisis is severe worsening of neuromuscular transmission causing bulbar and respiratory failure. Look for fatigable ptosis/diplopia, nasal speech, dysphagia, weak neck flexion, inability to count, weak cough and progressive respiratory effort. Infection and aspiration are frequent precipitants; missed treatment and medicines that impair neuromuscular transmission can also contribute.
- Admit to a monitored area and involve neurology/critical care early.
- Assess serial respiratory function and swallow; keep nil by mouth if bulbar weakness is present.
- Treat infection, aspiration and other triggers; review every medication with pharmacy/neurology.
- Continue or adjust cholinesterase-inhibitor therapy only under specialist direction because secretions, bradycardia and cholinergic toxicity can worsen airway care.
- Rapid immunotherapy such as IVIG or plasma exchange is specialist treatment for crisis; the choice depends on resources, contraindications and local protocol.
- Plan early airway management rather than waiting for exhaustion. Distinguish myasthenic crisis from excessive cholinergic effect with specialist support.
Guillain–Barré syndrome
GBS is an acute immune-mediated peripheral neuropathy often preceded by respiratory or gastrointestinal infection. Progressive symmetrical weakness, reduced reflexes, paraesthesia, facial weakness, bulbar dysfunction and autonomic instability are characteristic. Respiratory failure can develop quickly, sometimes before severe limb weakness is obvious.
- Admit patients with progression, bulbar symptoms, autonomic instability, weak cough or respiratory decline to a monitored setting.
- Measure serial respiratory function and perform frequent cranial-nerve, limb-power and swallowing assessments.
- Watch for BP swings, tachy/bradyarrhythmia, ileus, urinary retention, pain, DVT, pressure injury and dysautonomia.
- IVIG or plasma exchange are disease-modifying treatments prescribed by neurology; corticosteroids alone are not a substitute for specialist therapy.
- Intubate early when airway protection or ventilation is failing; avoid emergency delay caused by waiting for CSF or nerve-conduction confirmation.
Other neuromuscular emergencies
- Botulism: descending symmetrical paralysis with cranial-nerve signs; secure airway early, notify public health and arrange antitoxin urgently.
- Spinal cord compression: weakness with sensory level, back pain or sphincter dysfunction; immobilise if trauma, obtain urgent imaging and call neurosurgery.
- High cervical spinal injury: protect the spine, support ventilation, assess neurogenic shock and transfer to trauma/spinal services.
- Organophosphate toxicity: secretions, bronchospasm, bradycardia, fasciculations and weakness; decontaminate and use the poisoning protocol.
- Electrolyte paralysis: sudden flaccid weakness with ECG changes; obtain urgent electrolytes and treat life-threatening potassium abnormalities.
- Critical-illness/polyneuropathy: weakness after prolonged sepsis or ICU stay; prevent secondary complications and involve rehabilitation early.
Airway and medication safety
Medication caution: Sedatives, opioids, magnesium, aminoglycosides, fluoroquinolones, macrolides, beta-blockers, some antiarrhythmics and neuromuscular blockers can worsen weakness or respiratory failure. Check the diagnosis, current medicines, renal function and local interaction guidance before administration.
- Prepare suction, bag-mask ventilation, difficult-airway equipment and capnography before sedating or transporting a weak patient.
- Use the lowest effective sedative/analgesic dose with continuous respiratory monitoring.
- Review missed pyridostigmine or steroid doses with neurology; do not make abrupt changes independently.
- Document medicine time, dose, respiratory response, secretions, heart rate and blood pressure.
Nursing care and monitoring
- Record respiratory rate, effort, SpO₂, blood gas results, cough strength, secretion load, swallowing, vital capacity and level of consciousness.
- Maintain upright positioning, oral care, suction readiness, aspiration precautions and physiotherapy/cough-assist plan.
- Reposition regularly, protect pressure areas, provide DVT prevention and maintain nutrition/hydration safely.
- Monitor autonomic instability in GBS: sudden hypertension, hypotension, tachycardia, bradycardia, sweating or ileus.
- Use communication aids for patients who cannot speak; agree on a yes/no signal before fatigue worsens.
- Handover trend, airway plan, home ventilation settings, medication timing, last swallow and escalation thresholds.
Complications
| Complication | Clues | Response |
|---|---|---|
| Hypercapnic respiratory failure | Drowsiness, headache, confusion, rising PaCO₂ or acidosis. | Urgent critical-care review and ventilatory support; do not rely on oxygen alone. |
| Aspiration pneumonia | Choking, wet voice, fever, crackles, hypoxia or new infiltrate. | Nil by mouth, suction, imaging, antibiotics when indicated and airway review. |
| Autonomic dysreflexia/instability | Sudden BP changes, arrhythmia, sweating, flushing or bradycardia. | Continuous monitoring and specialist management of the trigger. |
| Pressure injury and DVT | Immobility, limb swelling, skin breakdown or pain. | Repositioning, skin care, prophylaxis and investigation when suspected. |
| Medicine-related weakness | Decline after sedative, antibiotic, magnesium or neuromuscular blocker. | Stop/review culprit medicine, support airway and call pharmacy/neurology. |
| Prolonged ventilator dependence | Weak cough, failed spontaneous-breathing trials, secretion retention. | Multidisciplinary weaning, physiotherapy, nutrition and rehabilitation plan. |
Clinical scenarios
Scenario 1 – Myasthenic crisis: A patient with myasthenia develops nasal speech, choking, weak neck flexion and a falling single-breath count after pneumonia. Keep upright and nil by mouth, suction, monitor serial respiratory function, treat infection, call neurology/critical care and prepare controlled ventilation.
Scenario 2 – Guillain–Barré syndrome: A patient with ascending weakness becomes tachypnoeic and cannot cough effectively. Do not wait for severe hypoxia; obtain blood gas/serial respiratory measurements, monitor autonomic function, arrange ICU and early airway planning.
Scenario 3 – Drug interaction: A patient with neuromuscular disease receives a sedative and becomes drowsy with shallow breathing. Stop further sedatives, support airway/ventilation, check gas/glucose and escalate immediately.
Common errors to avoid
- Using normal SpO₂ to rule out respiratory muscle failure.
- Waiting for cyanosis, exhaustion or arrest before calling anaesthesia/ICU.
- Giving sedatives, opioids, magnesium or interacting antibiotics without a risk review.
- Applying NIV to a patient who cannot protect the airway or clear secretions.
- Performing repeated tests while delaying treatment of infection, aspiration or metabolic triggers.
- Failing to document baseline function, home ventilation and the patient’s communication signal.
- Assuming weakness is psychogenic, especially when symptoms are progressive or bulbar.
WEAK AIRWAY: W – Watch work of breathing; E – Examine bulbar function; A – Assess CO₂ and airway; K – Keep suction/critical care ready; A – Avoid harmful medicines; I – Identify trigger; R – Respiratory support early; W – Wean and rehabilitate; A – Aspiration prevention; Y – Your handover must include trends.
Revision questions
- Why can SpO₂ remain normal during early neuromuscular hypoventilation?
- List clinical signs of impending ventilatory failure.
- How do myasthenic crisis and Guillain–Barré syndrome differ clinically?
- When is NIV unsafe in neuromuscular weakness?
- Which investigations assess respiratory muscle strength and CO₂ retention?
- List medicines that may worsen neuromuscular transmission.
- What nursing interventions reduce aspiration, pressure injury and DVT?
Key takeaways
- Respiratory muscle failure can be silent; trend effort, cough, bulbar function and CO₂.
- Plan the airway early and involve critical care before exhaustion.
- Treat myasthenic crisis, GBS, toxins, infection and metabolic triggers through specialist pathways.
- Use NIV selectively and never delay intubation when airway protection is failing.
- Medication review, secretion care, aspiration prevention and communication planning are essential.